SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question

Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-158. doi: 10.1016/S2468-1253(21)00008-X. Epub 2021 Jan 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity
  • COVID-19 Vaccines* / immunology
  • COVID-19 Vaccines* / pharmacology
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Clinical Trials as Topic
  • Humans
  • Immunogenicity, Vaccine
  • Liver Diseases* / immunology
  • Liver Diseases* / therapy
  • Liver Diseases* / virology
  • Needs Assessment
  • SARS-CoV-2 / immunology
  • Seroconversion / drug effects*
  • Vaccination / methods*

Substances

  • COVID-19 Vaccines